ES2171444T3 - Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales. - Google Patents

Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales.

Info

Publication number
ES2171444T3
ES2171444T3 ES94900537T ES94900537T ES2171444T3 ES 2171444 T3 ES2171444 T3 ES 2171444T3 ES 94900537 T ES94900537 T ES 94900537T ES 94900537 T ES94900537 T ES 94900537T ES 2171444 T3 ES2171444 T3 ES 2171444T3
Authority
ES
Spain
Prior art keywords
water
intravenous solution
body proteins
decreases loss
loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900537T
Other languages
English (en)
Inventor
Douglas Wilmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Application granted granted Critical
Publication of ES2171444T3 publication Critical patent/ES2171444T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/81—Energy rations, e.g. emergency rations, survival rations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTAN COMPOSICIONES Y METODOS PARA DISMINUIR LA PERDIDA DE NITROGENO DE MAMIFEROS NORMALMENTE ASOCIADA A LA ADMINISTRACION DE SOLUCIONES ISOCALORICAS. ESPECIFICAMENTE EN LA INVENCION SE PRESENTAN COMPOSICIONES QUE CONTIENEN DE UN 4% A UN 10% DE DEXTROSA Y DE UN 1/2% APROXIMADAMENTE A UN 2% DE GLUTAMINA. TALES COMPOSICIONES, CUANDO SE ADMINISTRAN A UN MAMIFERO, REDUCEN LA DESHIDRATACION Y LA PERDIDA DE NITROGENO A UN 25% APROXIMADAMENTE RESPECTO A LAS QUE SE DAN CUANDO NO SE ADMINISTRA LA SOLUCION.
ES94900537T 1992-11-06 1993-11-05 Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales. Expired - Lifetime ES2171444T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/971,623 US5292722A (en) 1992-11-06 1992-11-06 Intravenous solution that diminishes body protein loss

Publications (1)

Publication Number Publication Date
ES2171444T3 true ES2171444T3 (es) 2002-09-16

Family

ID=25518618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900537T Expired - Lifetime ES2171444T3 (es) 1992-11-06 1993-11-05 Una solucion intravenosa que disminuye las perdidas de proteinas y de agua corporales.

Country Status (9)

Country Link
US (1) US5292722A (es)
EP (1) EP0666739B1 (es)
AT (1) ATE211908T1 (es)
AU (1) AU5548894A (es)
DE (1) DE69331465T2 (es)
DK (1) DK0666739T3 (es)
ES (1) ES2171444T3 (es)
PT (1) PT666739E (es)
WO (1) WO1994010988A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649746B1 (en) 1999-05-07 2003-11-18 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
US6221910B1 (en) * 1999-07-22 2001-04-24 The University Of New Mexico Glutamine containing oral replacement solution
JP2003521256A (ja) * 2000-02-01 2003-07-15 マッスルテク リサーチ アンド ディヴェロプメント インコーポレーション 無脂肪筋量及び筋力を増強するためのαリポ酸含有食物補充物質
US6423349B1 (en) 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
AU2006242640A1 (en) * 2005-04-29 2006-11-09 Wyeth Drug delivery devices and related components, systems and methods
US7566463B2 (en) * 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
US20080065088A1 (en) * 2006-09-07 2008-03-13 Wyeth Bone Cement Mixing Systems and Related Methods
WO2016122791A1 (en) * 2015-01-30 2016-08-04 The Regents Of The University Of California Spinal subpial gene delivery system
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
KR102489437B1 (ko) 2016-03-28 2023-01-16 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뉴런 과흥분성 치료를 위한 방법 및 조성물
WO2019051202A1 (en) 2017-09-08 2019-03-14 The Regents Of The University Of California METHOD AND COMPOSITION FOR TREATING NEUROPATHIC PAIN
WO2020146718A1 (en) 2019-01-10 2020-07-16 The Regents Of The University Of California Subpial delivery system and methods of use
USD963164S1 (en) 2020-01-09 2022-09-06 The Regents Of The University Of California Surgical needle

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1909591A (en) * 1928-06-20 1933-05-16 Novocol Chemical Mfg Co Inc Method of utilizing hypodermic medicaments, etc.
US2283817A (en) * 1941-05-24 1942-05-19 William R Warner & Company Inc Detoxicant
US2662046A (en) * 1948-06-19 1953-12-08 Merck & Co Inc Parenteral amino acid solution
US2868693A (en) * 1956-07-16 1959-01-13 Shive William Peptic ulcer-treating compositions containing glutamine
US3217711A (en) * 1963-08-01 1965-11-16 Abbott Lab Valve apparatus for sequentially administering parenteral fluid from separate sources
US3195778A (en) * 1963-09-17 1965-07-20 Alta Engineering Company Storage and mixing cartridge
GB1125820A (en) * 1965-12-24 1968-09-05 Kyowa Hakko Kogyo Company Ltd The uses of glutamic acid derivatives as preservatives
US3701666A (en) * 1968-02-14 1972-10-31 Morton Norwich Products Inc Process for making amino acid composition
US3574857A (en) * 1968-04-01 1971-04-13 Smith Kline French Lab Antilipidemic methods using glutamic acid,threonine and proline
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
US3920838A (en) * 1973-09-04 1975-11-18 Flatt Jean Pierre Amino acid therapy
US3982534A (en) * 1975-01-10 1976-09-28 Buckman Thomas P Intravenous administration system
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
US4200095A (en) * 1977-08-15 1980-04-29 Millipore Corporation Arrangement for intravenous administration or the like
US4265240A (en) * 1979-04-16 1981-05-05 Imed Corporation Apparatus for providing a controlled introduction of intravenous fluid to a patient
JPS56131554A (en) * 1980-03-17 1981-10-15 Kaken Pharmaceut Co Ltd Novel d-glutamic acid derivative, its preparation, and immunizing agent containing said derivative as effective component
US4334535A (en) * 1980-08-12 1982-06-15 Cutter Laboratories, Inc. Conduit device for rapid priming and flow of liquid
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
SE8101247L (sv) * 1981-02-26 1982-08-27 Haessle Ab Lekemedelsadministrationsanordning
US4396383A (en) * 1981-11-09 1983-08-02 Baxter Travenol Laboratories, Inc. Multiple chamber solution container including positive test for homogenous mixture
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
GB8300011D0 (en) * 1983-01-04 1983-02-09 Fujisawa Pharmaceutical Co Glutamic acid derivatives
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
US4857555A (en) * 1985-09-12 1989-08-15 Brigham & Women's Hospital Method of treating catabolic dysfunction
SE8902544L (sv) * 1989-07-17 1991-01-18 Kabivitrum Ab Beredning foer naeringstillfoersel, samt saett foer dess framsaellning
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats

Also Published As

Publication number Publication date
PT666739E (pt) 2002-05-31
DE69331465D1 (de) 2002-02-21
US5292722A (en) 1994-03-08
DK0666739T3 (da) 2002-04-22
AU5548894A (en) 1994-06-08
EP0666739A1 (en) 1995-08-16
WO1994010988A1 (en) 1994-05-26
EP0666739B1 (en) 2002-01-16
DE69331465T2 (de) 2002-11-07
EP0666739A4 (en) 1996-02-28
ATE211908T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
GT199800126A (es) Terapia de combinacion.
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
DE10199011I1 (de) Asp-B28-Insulinkristalle
KR940005285A (ko) 염증성 장 질환, 염증성 피부 질환 및 자반증의 예방 및 치료용 약제제조를 위한 상보적 억제제의 용도
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
FR2702148B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
DK0460062T3 (da) Huperzin A-analoger
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
JPS6434909A (en) Cosmetic
KR900014382A (ko) (s)-7-(3-아미노-1-피롤리디닐)-1-시클로프로필-6-플루오로-1,4-디히드로-4-옥소-나프티리딘-3-카르복실산
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
FI910112A0 (fi) Preparat foer lokalt bruk.
GR3021171T3 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
ES2162794T3 (es) Compuestos farmaceuticos que contienen ametocaina.
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
ITRM930034A0 (it) Agente attivo per ridurre il livello ematico di glucocorticoidi e prevenire disturbi cerebrali da stress e senilita'.
KR910007540A (ko) 혈구 감소 장해의 예방ㆍ치료제
CA2089309A1 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 666739

Country of ref document: ES